MSU
NRXP icon

Mizuho Securities USA’s NRX Pharmaceuticals NRXP Stock Holding History

Mizuho Securities USA’s Portfolio NRXP Stock Details NRXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-30,306
Closed -$3.21M – 188
2019
Q3 		$3.21M Sell
30,306
-33,421
-52% -$3.5M 0.19% 50
2019
Q2 		$6.67M Buy
63,727
+40,868
+179% +$4.25M 0.31% 23
2019
Q1 		$2.36M Buy
22,859
+10,555
+86% +$1.08M 0.18% 62
2018
Q4 		$1.25M Buy
+12,304
New +$1.24M 0.17% 71

Other funds holding NRXP

PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
KPF
K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return
YCM
Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return
VOAM
Vertex One Asset Management Vancouver, British Columbia, Canada $434M AUM 37.82% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return
PMAM
Picton Mahoney Asset Management Toronto, Ontario, Canada $13.5B AUM 50.48% 1-Year Est. Return

Mizuho Securities USA's NRXP Position: Q4 2019 in Review

Mizuho Securities USA sold out of NRX Pharmaceuticals (NRXP) in Q4 2019, closing a stake of 30,306 shares — an estimated $3.21M sold.

Mizuho Securities USA first reported a position in NRXP in Q4 2018 and held it in 4 quarters. The position peaked at $6.67M in Q2 2019. 13 funds tracked by Wall St. Rank hold NRXP as of Q4 2019.

  • Mizuho Securities USA reported no remaining NRX Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
  • Mizuho Securities USA sold 30,306 NRX Pharmaceuticals shares in Q4 2019, an estimated $3.21M.
  • Mizuho Securities USA first reported a position in NRX Pharmaceuticals in Q4 2018 and held it in 4 quarters.
  • Mizuho Securities USA's NRX Pharmaceuticals position peaked at $6.67M in Q2 2019.
  • 13 funds tracked by Wall St. Rank held NRX Pharmaceuticals as of Q4 2019.

Based on Mizuho Securities USA's 13F filing for Q4 2019, filed 30 Jan 2020.